In this episode of Expert Voices in oncology, Emma Ter-Azaryan, Editorial Lead of OncoDaily TV, speaks with Glendon Zinser, Director of Scientific Strategy and Forums at Susan G. Komen, about advancing the mission to end breast cancer forever. From Susan G. Komen’s history and patient-centered vision to its groundbreaking research investments, Glendon shares how the organization has become a global leader in breast cancer advocacy and innovation.
Key moments in the conversation:
- Susan G. Komen’s 360° approach: research, community health, direct services, and policy
- $1.1 billion invested in research — supporting over 2,300 investigators
- How Komen played a role in developing 29 of 30 breast cancer drugs used today
- The creation of the IBC Scoring System and its global impact
- Advocacy that led to new ICD codes for IBC, effective October 2025